Smith & Nephew slumps to loss as surgery paused
Hip and knee replacement firm Smith & Nephew swung to a $34m (£26m) loss during the first half of the year as the pandemic led to the cancellation of elective surgeries worldwide. The FTSE 100 company said it will pay investors an interim dividend of
14.4 cents per share despite tumbling to a loss from a $383m profit a year earlier. Sales fell 29pc to $901m.